Speaker illustration

Doctor Steven Hageman

University Medical Center Utrecht, Utrecht (Netherlands (The))

Wrap-Up and initiation of discussion

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Risk Assessment

Session: Cardiovascular risk assessment: are we missing something?

Thumbnail

Prediction of lifetime cardiovascular risk and individual lifetime treatment benefit in four European risk regions: geographic recalibration of the LIFE-CVD model

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment - Scores 2

Thumbnail

The value of additional risk factors for improving 10-year cardiovascular risk prediction in apparently healthy people

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment and scores

Thumbnail

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Event: ESC Congress 2022

Topic: Cardiovascular Risk Assessment

Session: Cardiovascular risk assessment and scores

Thumbnail

The SMART risk model

Event: ESC Preventive Cardiology 2022

Topic: European Association of Preventive Cardiology (EAPC)

Session: New models for cardiovascular risk assessment

Thumbnail

SCORE2-OP.

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: The SCORE2 and SCORE2-Op risk algorithms to estimate ASCVD risk

Thumbnail

Predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease

Event: ESC Congress 2020

Topic: Cardiovascular Risk Assessment

Session: Young Investigator Award Session Population Sciences

Thumbnail

Major adverse limb events (MALE) and the relation with classical risk factors in patients with symptomatic cardiovascular disease

Event: ESC Congress 2019

Topic: Epidemiology

Session: Risk Factors and Prevention, Cardiovascular Disease in Special Populations

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb